You are viewing: US Bioresorbable Polymers Market analysis
Part of: Bioresorbable Polymers Market (Global)

The US Bioresorbable Polymers Market was valued at $133.3 Million in 2024 and projected to reach to $224.9 Million by 2029, representing a compound annual growth rate of 11.0%. The US bioresorbable polymers market is poised for sustained expansion through 2029, driven by increasing regulatory approvals, growing adoption in orthopedic and cardiovascular applications, and rising demand for minimally invasive surgical solutions.

US Bioresorbable Polymers Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Bioresorbable Polymers Market Trends and Insights

  • This 11.0% compound annual growth rate reflects strong demand across medical device, pharmaceutical, and surgical applications in the US healthcare sector.
  • The US market benefits from advanced manufacturing infrastructure, significant R&D investment, and regulatory frameworks that support innovation in biodegradable materials. Driving the US market expansion are increasing adoption of bioresorbable implants, growing preference for minimally invasive surgical procedures, and rising healthcare expenditure.
  • The US pharmaceutical and medical device industries are leveraging bioresorbable polymers for drug delivery systems, orthopedic implants, and tissue engineering scaffolds.
  • Between 2024 and 2029, the US is expected to maintain its position as a leading market for bioresorbable polymer applications, supported by favorable reimbursement policies and strong clinical evidence. The US competitive landscape features both established chemical manufacturers and specialized biotech firms developing next-generation bioresorbable solutions.
  • Market consolidation and strategic partnerships are accelerating innovation cycles, positioning the US as a hub for bioresorbable polymer commercialization and clinical deployment..

Key Market Statistics

  • CAGR (2024-2029) 11.0% CAGR
  • Market Size, 2024 ~USD 133.3 Million
  • Forecast, 2029 ~USD 224.9 Million
  • Country US

US Bioresorbable Polymers Market Overview

Market Valuation :

The US bioresorbable polymers market is valued at $133.3 million in 2024, with projections reaching $224.9 million by 2029, representing significant growth in the American healthcare sector.

Strong CAGR Growth :

The US market is expanding at an 11.0% CAGR through 2029, driven by increasing adoption in medical devices, surgical applications, and pharmaceutical delivery systems across American healthcare institutions.

Advanced Manufacturing Infrastructure :

The US benefits from world-class manufacturing capabilities and established supply chains, enabling rapid commercialization of bioresorbable polymer innovations and supporting domestic production capacity.

R&D Investment Leadership :

Significant investment in research and development by US pharmaceutical and medical device companies accelerates innovation in bioresorbable polymer technologies and clinical applications.

US Bioresorbable Polymers Market Dynamics

  • Healthcare providers and manufacturers are increasingly prioritizing bioresorbable materials due to their biocompatibility advantages and reduced need for surgical removal procedures. Key growth catalysts include expanding applications in drug delivery systems, tissue engineering scaffolds, and surgical implants across major US medical centers.
  • The convergence of advanced manufacturing technologies, favorable FDA regulatory pathways, and substantial healthcare spending positions the US market as a critical growth engine for bioresorbable polymer innovation and commercialization..

Related Ecosystem

Green Bio Chemicals

Top Technologies
  • Animal-Based Sealants
  • Bacterial Fermentation
  • Corrosion Inhibitors
  • Hydrogen Peroxide
  • Nitrile Butadiene Rubber (NBR)
Top Companies
  • Basf se
  • Evonik industries ag
  • Solvay sa
  • AZELIS HOLDINGS SA
  • CARGILL, INCORPORATED

    Resins And Polymers

    Top Technologies
    • Polycarbonate
    • Acrylonitrile Butadiene Styrene (ABS)
    • Epoxy Resin
    • Light Commercial Vehicles (LCVs)
    • Polypropylene (PP)
    Top Companies
    • Basf se
    • DOW CHEMICAL COMPANY
    • Solvay sa
    • Saudi arabia basic industries corporation (sabic)
    • DuPont de Nemours, Inc.

      Key Takeaways

      • The US bioresorbable polymers market is valued at $133.3 million in 2024 and will reach $224.9 million by 2029, growing at 11.0% CAGR.
      • The US medical device and pharmaceutical sectors are primary drivers, with increasing adoption of bioresorbable implants and drug delivery systems.
      • The US regulatory environment and reimbursement policies create favorable conditions for bioresorbable polymer innovation and commercialization.
      • The US market is characterized by strategic partnerships and consolidation among established manufacturers and specialized biotech firms.

      Bioresorbable Polymers Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment PLGA (Type)
      Forecast Period 2024-2029
      Growth Rate CAGR of 11.6% from 2024 to 2029
      Largest Segment ORTHOPEDIC DEVICES (Application)
      Market Size Base Year (Billions) ~USD 0.5 (2024)
      Revenue Forecast (Billions) ~USD 0.87 (2029)
      Segments Covered Type, Application

      US Bioresorbable Polymers Market Report Segmentation

      2 segment dimensions are covered across the global market.

      By Type

      • Other Types
      • Pcl
      • Pga
      • Pla
      • Plga
      • -Pdlla
      • -Plla

      By Application

      • Drug Delivery
      • Hip
      • Knee
      • Oral
      • Orthopedic Devices
      • Other Applications
      • Other Drug Delivery Applications
      • Other Orthopedic Device Applications
      • Parenteral
      • Spine
      • Sports Injury
      • Trauma

      US: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023–2029

      Segment2023202420252026202720282029CAGR (%)
      DRUG DELIVERY46.3350.8856.2262.4669.8178.2287.7911.5
      ORTHOPEDIC DEVICES64.4370.2176.9984.8994.15104.68116.5710.7
      OTHER APPLICATIONS11.1912.2213.4414.8516.5118.4120.5510.9
      TOTAL121.95133.31146.65162.2180.47201.31224.911

      Target Audience

      • Medical Device Manufacturers : US-based and international medical device companies need market intelligence to develop bioresorbable polymer-based implants, surgical tools, and devices aligned with American healthcare demand and regulatory requirements.
      • Pharmaceutical Companies : Pharmaceutical firms require US market insights to evaluate bioresorbable polymers for drug delivery systems, controlled-release formulations, and innovative therapeutic delivery mechanisms in the American market.
      • Healthcare Investors & PE Firms : Investment professionals need validated US market data, growth forecasts, and competitive analysis to identify high-potential bioresorbable polymer companies and assess investment returns in the American healthcare sector.
      • Material Science & Polymer Manufacturers : Raw material suppliers and polymer producers require US market demand forecasts and application trends to optimize production capacity, develop specialized formulations, and expand distribution networks.
      • Healthcare Institutions & Hospitals : US hospitals and surgical centers need market insights on bioresorbable polymer adoption trends, cost-benefit analyses, and clinical outcomes to inform procurement decisions and surgical protocol updates.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise US market valuation ($133.3M in 2024) and verified 5-year forecast data to support strategic planning, investment decisions, and competitive positioning in the American bioresorbable polymers sector.
      • US-Specific Regulatory Insights : Understand FDA approval pathways, regulatory requirements, and compliance standards specific to the US market, enabling faster product development and market entry strategies for bioresorbable polymer solutions.
      • Competitive Landscape Analysis : Identify leading US manufacturers, emerging players, and market consolidation trends to benchmark competitive positioning and identify partnership or acquisition opportunities within the American market.
      • Application-Specific Demand Drivers : Analyze US healthcare sector demand across orthopedic, cardiovascular, and surgical applications to prioritize R&D investments and tailor product development for high-growth medical device segments.
      • Investment & Expansion Strategy : Leverage US market data to justify capital allocation, manufacturing facility expansion, and market entry decisions with data-backed growth projections and regional opportunity assessments.

      Frequently asked questions

      What is the current size of the US bioresorbable polymers market?

      The US bioresorbable polymers market was valued at $133.3 million in 2024 and is expected to grow to $224.9 million by 2029.

      What is the growth rate of the US bioresorbable polymers market?

      The US bioresorbable polymers market is projected to grow at a compound annual growth rate (CAGR) of 11.0% from 2024 to 2029.

      Which applications drive demand in the US bioresorbable polymers market?

      Key applications in the US include medical device implants, pharmaceutical drug delivery systems, orthopedic implants, and tissue engineering scaffolds.

      What factors support growth in the US bioresorbable polymers market?

      Growth is driven by increasing adoption of minimally invasive procedures, rising healthcare expenditure, favorable regulatory frameworks, and strong clinical evidence supporting bioresorbable solutions.

      Who are the major players in the US bioresorbable polymers market?

      The US market includes established chemical manufacturers, specialized biotech firms, and medical device companies engaged in developing and commercializing bioresorbable polymer solutions.

      RESEARCH METHODOLOGY

      The study involved four major activities in estimating the market size for bioresorbable polymers market. Exhaustive secondary research was done to collect information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, the market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

      Secondary Research

      Secondary sources used in this study included annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles from recognized authors; and gold standard & silver standard websites such as Factiva, ICIS, Bloomberg, and others. The findings of this study were verified through primary research by conducting extensive interviews with key officials such as CEOs, VPs, directors, and other executives. The breakdown of profiles of the primary interviewees is illustrated in the figure below:

      Primary Research

      The bioresorbable polymers market comprises several stakeholders, such as raw material suppliers, end-product manufacturers, and regulatory organizations in the supply chain. The demand side of this market is characterized from key opinion leaders in various applications for the bioresorbable polymers market. The supply side is characterized by advancements in technology and diverse application industries. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

      The following is a breakdown of the primary respondents:

      Note: Tier 1, Tier 2, and Tier 3 companies are classified based on their market revenue in 2022/ 2023, available in the public domain, product portfolios, and geographical presence.

      Other designations include consultants and sales, marketing, and procurement managers.

      To know about the assumptions considered for the study, download the pdf brochure

      COMPANY NAME DESIGNATION
      Evonik Industries AG Sales Manager
      Ashland Global Holdings Inc. R&D Manager
      KLS Martin Group Global R&D Head
      DSM Biomedical Business Development Manager
      Poly-Med Incorporated Regional Sales Manager

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the bioresorbable polymers market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • The key players in the industry have been identified through extensive secondary research.
      • The supply chain of the industry has been determined through primary and secondary research.
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
      • All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.

      Data Triangulation

      After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the bioresorbable polymers industry.

      Market Definition

      The bioresorbable polymers are the type of polymers. They are designed to naturally degrade and be absorbed within biological environments. These polymers are utilized in medical and healthcare sectors, where they are used to manufacture orthopedic devices and drug delivery systems. The demand of bioresorbable polymers influenced by the innovation in medical devices and the need for the eco-friendly alternatives to the permanent implants. The key components of the bioresorbable polymers are PLA, PGA, PLGA, and PCL.

      Stakeholders

      • Bioresorbable polymers manufacturers
      • Bioresorbable polymers suppliers
      • Raw material suppliers
      • Application sector companies
      • Government bodies

      Report Objectives

      • To define, describe, and forecast the bioresorbable polymers market in terms of value and volume
      • To provide detailed information regarding the drivers, opportunities, restraints, and challenges influencing market growth
      • To estimate and forecast the market size by type, application, and region
      • To forecast the size of the market for five main regions: Asia Pacific, Europe, North America, South America, and the Middle East & Africa, along with their key countries
      • To strategically analyze micromarkets1 with respect to their growth trends, prospects, and contribution to the overall market
      • To analyze opportunities in the market for stakeholders and provide a competitive landscape for market leaders
      • To analyze competitive developments, such as deals and expansions, in the market
      • To strategically profile key players and comprehensively analyze their growth strategies

      Get the Full Bioresorbable Polymers Market Report

      Full forecast, segment splits, and company analysis for all Bioresorbable Polymers Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status